The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Self-citationLong-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302 · cited 2×
“Along these lines, an atherogenic role of liver inflammation is supported by the observation that CVD risk is greater in NASH than in pure steatosis [33, 34, 38], and it is strongly associated with elevated serum liver enzymes, a surrogate marker of liver necro-inflammation [32, 36, 39–41].”
BackgroundVisceral fat adipokine secretion is associated with systemic inflammation in obese humans
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417 · cited 4×
“IL-6 and TNF-α are the major stimuli responsible for increased hepatic production of C-reactive protein (CRP), fibrinogen and other acute-phase proteins [44, 52].”
BackgroundInfluentialPrevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Self-citationAdiponectin and Metabolic Syndrome
Matsuzawa, Y., Funahashi, T., Kihara, S., & Shimomura, I. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000099786.99623.ef · Cited by 1,202
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
Self-citationBeyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #
Schwimmer, J. B., Behling, C., Newbury, R., Deutsch, R., Nievergelt, C., Schork, N. J., & Lavine, J. E. (2005) · Hepatology · doi:10.1002/hep.20842 · Cited by 747
(2011) · Hepatogastroenterology · doi:10.5754/hge11387 · Cited by 660
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Self-citationIncreased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
Korenblat, K. M., Fabbrini, E., Mohammed, B. S., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.075 · Cited by 592 · cited 1×
“Indeed, liver fat content in non-diabetic obese individuals is the best predictor of insulin action in the liver, skeletal muscle and adipose tissue, independent of percentage body fat [47].”
BackgroundTargher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Self-citationTargher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3541 · Cited by 574
Self-citationRuttmann, E., Brant, L. J., Concin, H., Diem, G., Rapp, K., Ulmer, H., & the Vorarlberg Health Monitoring and Promotion Program Study Group (2005) · Circulation · doi:10.1161/circulationaha.105.552547 · Cited by 556
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Lee, D. S., Evans, J. C., Robins, S. J., Wilson, P. W., Albano, I., Fox, C. S., Wang, T. J., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251993.20372.40 · Cited by 530
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
A comparison of fibrosis progression in chronic liver diseases
Poynard, T., Mathurin, P., Lai, C.-L., Guyader, D., Poupon, R., Tainturier, M.-H., Myers, R. P., Muntenau, M., Ratziu, V., Manns, M., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00413-0 · Cited by 474
Liver Fat in the Metabolic Syndrome
Kotronen, A., Westerbacka, J., Bergholm, R., Pietiläinen, K. H., & Yki-Järvinen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0482 · Cited by 457
Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults
Kim, H. J., Kim, H. J., Lee, K. E., Kim, D. J., Kim, S. K., Ahn, C. W., Lim, S.-K., Kim, K. R., Lee, H. C., Huh, K. B., et al. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2169 · Cited by 435
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G., & Tiribelli, C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.003 · Cited by 425
Self-citationSchindhelm, R. K., Dekker, J. M., Nijpels, G., Bouter, L. M., Stehouwer, C. D. A., Heine, R. J., & Diamant, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.006 · Cited by 420
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
de Marco, R., Locatelli, F., Zoppini, G., Verlato, G., Bonora, E., & Muggeo, M. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.756 · Cited by 405
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Zenari, L., Cigolini, M., Falezza, G., & Arcaro, G. (2006) · Diabetes Care · doi:10.2337/dc06-0135 · Cited by 401
Self-citationDay, C. P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.017 · Cited by 395
Ribeiro, P. S., Cortez-Pinto, H., Solá, S., Castro, R. E., Ramalho, R. M., Baptista, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40009.x · Cited by 395
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study
Brea, A., Mosquera, D., Martín, E., Arizti, A., Cordero, J. L., & Ros, E. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160613.57985.18 · Cited by 387
Wannamethee, G., Ebrahim, S., & Gerald Shaper, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117699 · Cited by 334
Kolak, M., Westerbacka, J., Velagapudi, V. R., Wågsäter, D., Yetukuri, L., Makkonen, J., Rissanen, A., Häkkinen, A.-M., Lindell, M., Bergholm, R., et al. (2007) · Diabetes · doi:10.2337/db07-0111 · Cited by 317
Yoneda, M., Mawatari, H., Fujita, K., Iida, H., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2060-x · Cited by 294 · cited 13×
“CRP C-reactive protein CVD cardiovascular disease HOMA-IR homeostasis model assessment of insulin resistance IMT intima–media thickness JNK c-Jun N-terminal kinase NAFLD non-alcoholic fatty liver disease NASH non-alcoholic steatohepatitis NF-κB nuclear factor-κB PAI-1 plasminogen activator inhibitor-1”
BackgroundInfluentialNonalcoholic Fatty Liver Disease
Adams, L. A., & Lindor, K. D. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.05.013 · Cited by 289
Hepatic steatosis is associated with an increased risk of carotid atherosclerosis
Völzke, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1848 · Cited by 248
Incidence and natural course of fatty liver in the general population: The Dionysos study
Bedogni, G., Miglioli, L., Masutti, F., Castiglione, A., Crocè, L. S., Tiribelli, C., & Bellentani, S. (2007) · Hepatology · doi:10.1002/hep.21827 · Cited by 226
Lee, D.-H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl086 · Cited by 224
Ioannou, G. N., Weiss, N. S., Boyko, E. J., Mozaffarian, D., & Lee, S. P. (2006) · Hepatology · doi:10.1002/hep.21171 · Cited by 220
NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Franchini, M., Zoppini, G., Muggeo, M., & Day, C. P. (2008) · Obesity · doi:10.1038/oby.2008.64 · Cited by 214
Self-citationPerseghin, G., Lattuada, G., De Cobelli, F., Esposito, A., Belloni, E., Ntali, G., Ragogna, F., Canu, T., Scifo, P., Del Maschio, A., et al. (2008) · Hepatology · doi:10.1002/hep.21983 · Cited by 210
Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
Fracanzani, A. L., Burdick, L., Raselli, S., Pedotti, P., Grigore, L., Santorelli, G., Valenti, L., Maraschi, A., Catapano, A., & Fargion, S. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.08.041 · Cited by 209
Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men
Targher, G., Bertolini, L., Padovani, R., Zenari, L., Zoppini, G., & Falezza, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2498 · Cited by 197
Self-citationKotronen, A., Juurinen, L., Hakkarainen, A., Westerbacka, J., Cornér, A., Bergholm, R., & Yki-Järvinen, H. (2008) · Diabetes Care · doi:10.2337/dc07-1463 · Cited by 196 · cited 1×
“Liver fat content is ∼80% higher in type 2 diabetic patients than in age-, sex- and BMImatched non-diabetic patients with NAFLD, and their serum liver enzymes are not as representative of the severity of intra-hepatic fat accumulation [13].”
BackgroundToledo, F. G. S., Sniderman, A. D., & Kelley, D. E. (2006) · Diabetes Care · doi:10.2337/dc06-0455 · Cited by 196
Lautamäki, R., Borra, R., Iozzo, P., Komu, M., Lehtimäki, T., Salmi, M., Jalkanen, S., Airaksinen, K. E. J., Knuuti, J., Parkkola, R., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00604.2005 · Cited by 170
REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia
Ginsberg, H. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2084 · Cited by 167
Fatty liver, insulin resistance, and dyslipidemia
Adiels, M., Taskinen, M., & Borén, J. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0011-4 · Cited by 165
Goland, S., Shimoni, S., Zornitzki, T., Knobler, H., Azoulai, O., Lutaty, G., Melzer, E., Orr, A., Caspi, A., & Malnick, S. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225668.53673.e6 · Cited by 162
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Arcaro, G., & Day, C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.021 · Cited by 162
Self-citationCartier, A., Lemieux, I., Alméras, N., Tremblay, A., Bergeron, J., & Després, J.-P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2191 · Cited by 161
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Sonographic fatty liver, overweight and ischemic heart disease
Lin, Y., Lo, H.-M., & Chen, J.-D. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i31.4838 · Cited by 142
Kotronen, A., Seppälä-Lindroos, A., Bergholm, R., & Yki-Järvinen, H. (2007) · Diabetologia · doi:10.1007/s00125-007-0867-x · Cited by 126
Gambino, R., Cassader, M., Pagano, G., Durazzo, M., & Musso, G. (2007) · Hepatology · doi:10.1002/hep.21631 · Cited by 118
Schindhelm, R. K., Diamant, M., Bakker, S. J. L., van Dijk, R. A. J. M., Scheffer, P. G., Teerlink, T., Kostense, P. J., & Heine, R. J. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01502.x · Cited by 112
Targher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Zenari, L., Zoppini, G., & Falezza, G. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349177 · Cited by 109
Self-citationPostprandial Lipemia Associates with Liver Fat Content
Matikainen, N., Mänttäri, S., Westerbacka, J., Vehkavaara, S., Lundbom, N. M. I., Yki‐Järvinen, H., & Taskinen, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0187 · Cited by 83
Liver: an alarm for the heart?
Mirbagheri, S. A., Rashidi, A., Abdi, S., Saedi, D., & Abouzari, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01531.x · Cited by 78
Is liver disease a threat to patients with metabolic disorders?
Marchesini, G., Forlani, G., & Bugianesi, E. (2005) · Annals of Medicine · doi:10.1080/07853890510011445 · Cited by 29
Self-citation
Cited by
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Self-citationA position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Self-citationYounossi, Z. M., Stepanova, M., Rafiq, N., Makhlouf, H., Younoszai, Z., Agrawal, R., & Goodman, Z. (2011) · Hepatology · doi:10.1002/hep.24268 · Cited by 638
Portillo-Sanchez, P., Bril, F., Maximos, M., Lomonaco, R., Biernacki, D., Orsak, B., Subbarayan, S., Webb, A., Hecht, J., & Cusi, K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1966 · Cited by 503
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Metadata
- Authors
- Targher, G., Marra, F., & Marchesini, G.
- Venue
- Diabetologia
- Published
- 2008-09-02
- Volume
- 51
- Issue
- 11
- Pages
- 1947-1953
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2086216913
- Cited by
- 378
- References
- 63
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.